Bacterial Outbreak Linked to EzriCare Eyedrops: CDC

UPDATED February 3, 2023 // Editor's note: This article has been updated with details of the recall.

A bacterial outbreak linked to eyedrops has caused one death and sickened at least 50 people in 11 states, the CDC says. Some patients have been hospitalized and some are now permanently blind.

"Recent epidemiology and laboratory evidence link these infections to use of EzriCare Artificial Tears," the CDC said in a statement. While no recall was initially called for, Global Pharma Healthcare, the manufacturer of the products, announced Thursday it was recalling all of its artificial tears drops sold in the US.

People should discontinue using EzriCare Artificial Tears, the agency advised. The over-the-counter product is available from retailers such as Walmart.

The bacteria, Pseudomonas aeruginosa , usually causes blood or lung infections that are resistant to many antibiotics. The bacteria type is present in the environment and commonly found in water and soil.

The illnesses occurred from May 17, 2022, to Jan. 19 in these states: California, Colorado, Connecticut, Florida, New Jersey, New Mexico, New York, Nevada, Texas, Utah, and Washington.

Based in New Jersey, EzriCare published a special website explaining that the company has not received any related consumer complaints.

In a statement on the website dated Jan. 24, the company said it "has not received communication from any regulatory agency providing any outcomes or details to EzriCare about the ongoing investigation. We have not been asked to conduct a recall."

The CDC said its investigation is ongoing.

Sources

CDC: "Update: Multistate Cluster of VIM- and GES-producing Carbapenemresistant Pseudomonas aeruginosa associated with Artificial Tears," "Pseudomonas aeruginosa in Healthcare Settings."

EzriCare: "EzriCare Artificial Tears - Discontinue Use, January 24, 2023."

Credit:
Lead image: Roblan | Dreamstime.com

Cite this: Bacterial Outbreak Linked to EzriCare Eyedrops: CDC - Medscape - Feb 01, 2023.

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

My Alerts